ArticleAsian Pacific journal of cancer prevention : APJCP2026
Analysis of Risk Factors and Assessment of miRNA-122 as a Novel Biomarker for Colon Cancer in Egyptian Patients.
Article in Asian Pacific journal of cancer prevention : APJCP, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundColon cancer is one of the most prevalent cancers in the world; some of its risk factors are controllable. A healthy lifestyle and early diagnosis significantly reduce colon cancer incidence and mortality. The aim of this study was to assess the most important risk factors for colon cancer in the Egyptian patients as well as the usefulness of miRNA-122 as diagnostic biomarker for colon cancer.
methodsIn this case control study, 102 colon cancer cases and equal number of controls were enrolled between April 2022 till June 2022 in two Egyptian centers. Both groups were assessed by a structured questionnaire, anthropometric measurements and serum levels of miRNA-122.
resultsDietary factors, older age, obesity, rural residence, prolonged use of non-steroidal anti-inflammatory drugs, and cigarette smoking were significantly associated with colon cancer in our study subjects. miRNA-122 demonstrated significant sensitivity and specificity for colon cancer diagnosis, with a cutoff value of 0.946.
conclusionThe most important risk factor for colon cancer in the Egyptian patients were smoking, obesity, diabetes, dyslipidemia and excessive processed meat intake with low vegetables consuption. Our study suggests miRNA-122 as a potential non-invasive diagnostic biomarker for colon cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.